India Glycols Ltd

India Glycols Ltd

India Glycols Ltd has fixed the effective date and record date for the scheme of arrangement, which involves the demerger of the company into two resulting companies, Ennature Bio Pharma Ltd and IGL Spirits Ltd, with the allotment of shares to shareholders.

India Glycols Ltd

India Glycols Ltd has fixed the effective date and record date for the allotment of shares pursuant to a scheme of arrangement. The effective date is September 1, 2026, and the record date is September 2, 2026. The scheme involves the demerger of the company into two resulting companies, Ennature Bio Pharma Limited and IGL Spirits Limited, and the allotment of shares to the shareholders of the demerged company.

India Glycols Ltd

India Glycols Ltd has announced the allotment of Equity Shares to successful applicants under its public issue, with 28,800 shares allotted to 1 successful applicant. The company has also obtained the listing and trading approval from NSE EMERGE and trading is expected to commence on August 21, 2026.

India Glycols Ltd

India Glycols Ltd has received a certified true copy of the NCLT order dated 17th July, 2026, approving the Scheme of Arrangement amongst India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited.

India Glycols Ltd

India Glycols Ltd has announced its Q1FY27 Earnings Conference Call transcript, showing a strong start to the fiscal year with double-digit growth in gross revenue, EBITDA, and PAT. The company's net revenue was INR1,130 crores, up 9%, with a record EBITDA of INR170 crores. The business restructuring front has made progress, with NCLT approval and actions being taken as per the plan.

India Glycols Ltd

India Glycols Ltd has announced the outcome of its 42nd Annual General Meeting (AGM), where all 4 proposed resolutions were passed with the requisite majority. The company has also disclosed the voting results and the consolidated scrutinizer's report.

India Glycols Ltd

India Glycols Ltd held its 42nd Annual General Meeting (AGM) on August 19, 2026, through video conference. The meeting was attended by 52 members, and all four resolutions were passed with the requisite majority. The company provided remote e-voting facilities for the resolutions, which commenced on August 15, 2026, and ended on August 18, 2026. The scrutinizer, Ashish Saxena, was present to ensure a fair and transparent voting process. The meeting was conducted in compliance with the Companies Act, 2013, and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

India Glycols Ltd

India Glycols Ltd clarifies on BSE query regarding volume movement, stating that there is no undisclosed information or event that needs to be disclosed under SEBI Listing Regulations.

India Glycols Ltd

India Glycols Ltd responded to a query from the National Stock Exchange (NSE) regarding a surge in trading volumes, stating that there is no undisclosed information or event concerning the company that needs to be disclosed under SEBI Listing Regulations. The company attributes the increased volume to market-driven factors and reaffirms its commitment to keeping the stock exchanges informed of all necessary information.

India Glycols Ltd

The Bombay Stock Exchange (BSE) has sought clarification from India Glycols Ltd regarding a significant movement in trading volume on August 19, 2026.

India Glycols Ltd

India Glycols Ltd has made the audio recording of its Q1FY27 Earnings Conference Call available on its website, as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

India Glycols Ltd

India Glycols Ltd has announced its Q1FY27 earnings, with a robust performance driven by a diversified portfolio and focused execution. The company has reported double-digit growth in Gross Revenue, EBITDA, and PAT. The proposed restructuring has received NCLT approval, with implementation activities progressing.

India Glycols Ltd

India Glycols Ltd has issued a reminder to its physical security holders to furnish their PAN, KYC details, and nomination for compliance with SEBI regulations.

India Glycols Ltd

India Glycols Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, with a net profit of Rs. 96.83 crore and earnings per equity share of Rs. 11.43.

India Glycols Ltd

India Glycols Ltd announces change in management with Ms. Pragya Bhartia Barwale being re-designated as a Non-Executive Non-Independent Director, effective August 12, 2026.

India Glycols Ltd

India Glycols Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, with a net profit of Rs. 96.83 crores, up 12.5% from the same period last year. Revenue from operations was Rs. 2,986.92 crores, up 25.7% from the same period last year.

India Glycols Ltd

India Glycols Ltd has announced the details of its Q1FY27 earnings conference call, to be held on 14th August 2026 at 16:00 Hrs IST. The call will be attended by the company's CEO, Executive Directors, CFO, and other key personnel. The dial-in details and contact information for any enquiries are provided.

India Glycols Ltd

India Glycols Ltd has announced an earnings conference call for Q1FY27, scheduled for August 14th, 2026, at 16:00 Hrs IST. The call will be attended by the company's CEO, Executive Directors, CFO, and other key personnel. The dial-in details and contact information for inquiries are provided.

India Glycols Ltd

India Glycols Ltd has announced the closure of its trading window from July 1, 2026, to August 14, 2026, due to an upcoming board meeting to consider unaudited financial results for Q1 2026.

India Glycols Ltd

India Glycols Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 to consider and approve Unaudited Financial Results (Standalone & Consolidated) for the first quarter ended 30th June, 2026.